company background image
COLO B logo

Coloplast CPSE:COLO B Voorraadrapport

Laatste prijs

DKK 890.00

Marktkapitalisatie

DKK 200.4b

7D

-4.2%

1Y

18.3%

Bijgewerkt

18 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Coloplast A/S

CPSE:COLO B Voorraadrapport

Marktkapitalisatie: DKK 200.4b

COLO B Overzicht aandelen

Coloplast A/S houdt zich bezig met de ontwikkeling en verkoop van producten en diensten voor de intieme gezondheidszorg in Denemarken, de Verenigde Staten, het Verenigd Koninkrijk, Frankrijk en internationaal. Meer informatie

COLO B fundamentele analyse
Sneeuwvlok Score
Waardering3/6
Toekomstige groei3/6
Prestaties in het verleden3/6
Financiële gezondheid2/6
Dividenden3/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

DKK 911.19
FV
2.3% undervalued intrinsic discount
8.48%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
11 days ago author updated this narrative

Coloplast A/S Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Coloplast
Historische aandelenkoersen
Huidige aandelenkoersDKK 890.00
52 Week HoogtepuntDKK 977.60
52 Week LaagDKK 739.60
Bèta0.34
11 maand verandering-0.71%
3 maanden verandering0.25%
1 Jaar Verandering18.32%
33 jaar verandering-24.67%
5 jaar verandering11.33%
Verandering sinds IPO6,865.22%

Recent nieuws en updates

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 13
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Nov 08
Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Recent updates

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 13
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Nov 08
Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Oct 18
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 23
Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Aug 22
Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

Jul 17
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jun 29
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Rendement voor aandeelhouders

COLO BDK Medical EquipmentDK Markt
7D-4.2%-1.2%-3.1%
1Y18.3%16.5%5.7%

Rendement versus industrie: COLO B overtrof de Danish Medical Equipment industrie, die het afgelopen jaar een rendement 16.5 % opleverde.

Rendement versus markt: COLO B overtrof de Danish markt, die het afgelopen jaar een rendement opleverde van 5.7 %.

Prijsvolatiliteit

Is COLO B's price volatile compared to industry and market?
COLO B volatility
COLO B Average Weekly Movement3.6%
Medical Equipment Industry Average Movement3.7%
Market Average Movement4.2%
10% most volatile stocks in DK Market10.5%
10% least volatile stocks in DK Market2.4%

Stabiele aandelenkoers: COLO B heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van COLO B is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
195416,639Kristian Villumsenwww.coloplast.com

Coloplast A/S houdt zich bezig met de ontwikkeling en verkoop van producten en diensten voor de intieme gezondheidszorg in Denemarken, de Verenigde Staten, het Verenigd Koninkrijk, Frankrijk en internationaal. Het bedrijf is actief in de segmenten Chronische zorg, Continentiezorg, Stem- en ademhalingszorg, Interventionele Urologie en Geavanceerde wondzorg. Het bedrijf levert producten voor stomazorg, waaronder SenSura Mio, dat individuele lichaamsvormen en optimale discretie biedt voor verschillende soorten stomazorg; en SenSura Ostomy care solutions, evenals stomazorgaccessoires onder het merk Brava.

Coloplast A/S Samenvatting

Hoe verhouden de winst en inkomsten van Coloplast zich tot de beurswaarde?
COLO B fundamentele statistieken
MarktkapitalisatieDKK 200.37b
Inkomsten(TTM)DKK 5.05b
Inkomsten(TTM)DKK 27.03b

39.7x

Koers/Winstverhouding

7.4x

P/S-verhouding

Is COLO B overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
COLO B resultatenrekening (TTM)
InkomstenDKK 27.03b
Kosten van inkomstenDKK 8.76b
BrutowinstDKK 18.27b
Overige uitgavenDKK 13.22b
InkomstenDKK 5.05b

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

Feb 04, 2025

Winst per aandeel (EPS)22.44
Brutomarge67.59%
Nettowinstmarge18.69%
Schuld/Eigen Vermogen Verhouding120.6%

Hoe presteerde COLO B op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.5%

Huidig dividendrendement

98%

Uitbetalingsratio

Betaalt COLO B een betrouwbaar dividend?

Zie COLO B dividendgeschiedenis en benchmarks
Wanneer moet je COLO B kopen om een aanstaand dividend te ontvangen?
Coloplast dividenddata
Ex Dividend DatumDec 06 2024
Betaaldatum dividendDec 10 2024
Dagen tot Ex-dividend17 days
Dagen tot dividendbetaaldatum21 days

Betaalt COLO B een betrouwbaar dividend?

Zie COLO B dividendgeschiedenis en benchmarks